Insulin resistance and atherosclerosis

Considerable evidence supports the association between insulin resistance and vascular disease, and this has led to wide acceptance of the clustering of hyperlipidemia, glucose intolerance, hypertension, and obesity as a clinical entity, the metabolic syndrome. While insulin resistance, by promoting...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of clinical investigation Vol. 116; no. 7; pp. 1813 - 1822
Main Author Semenkovich, Clay F
Format Journal Article
LanguageEnglish
Published United States American Society for Clinical Investigation 01.07.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Considerable evidence supports the association between insulin resistance and vascular disease, and this has led to wide acceptance of the clustering of hyperlipidemia, glucose intolerance, hypertension, and obesity as a clinical entity, the metabolic syndrome. While insulin resistance, by promoting dyslipidemia and other metabolic abnormalities, is part of the proatherogenic milieu, it is possible that insulin resistance itself in the vascular wall does not promote atherosclerosis. Recent findings suggest that insulin resistance and atherosclerosis could represent independent and ultimately maladaptive responses to the disruption of cellular homeostasis caused by the excess delivery of fuel.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0021-9738
1558-8238
DOI:10.1172/JCI29024